Directory · FI
Biotechnology Research in Finland
A register of firms and the professionals working at them in the Biotechnology Research sector based in Finland. Browse the public index, then filter or export on Kipplo.
Companies
125 on file
Roche Finland
Roche kehittää innovatiivisia lääkehoitoja ja diagnostisia testejä tarjotakseen potilaille enemmän aikaa läheistensä kanssa. Yhdessä yhteistyökumppaneidemme kanssa olemme mukana ratkaisemassa terveydenhuollon haasteita, edistämme parempaa hoitoa ja kehitämme hoitopolkuja varhaisesta diagnoosista aina yksilöityyn lääkehoitoon. Roche on globaali lääkealan ja diagnostiikan edelläkävijä. Suomessa Roche toimii kahtena eri yrityksenä. Diagnostiikasta vastaa Roche Diagnostics Oy ja lääkeliiketoiminnasta Roche Oy. Päivitämme tälle LinkedIn-sivulle molempien yritysten kuulumisia. Terveydenhuolto on merkityksellistä meille kaikille. Siksi työskentelemme varmistaaksemme, että innovaatiomme olisivat nopeasti saatavilla kaikille niitä tarvitseville suomalaisille potilaille yhteiskunnan resurssien näkökulmasta kestävällä tavalla. Roche sijoittaa vuosittain yli 20 % globaalista liikevaihdostaan tutkimus- ja tuotekehitystoimintaan. Näin varmistamme valmiudet yhä uusiin tieteellisiin, diagnostisiin ja digitaalisiin harppauksiin syöpätautien ja hematologisten sairauksien, keskushermostosairauksien ja silmätautien aloilla. Yhdistämällä yksilöityä diagnostiikan ja lääkekehityksen osaamista pyrimme nopeuttamaan uusien, potilaiden hoitoa mullistavien ratkaisujen kehittämistä. Tämä tavoite tekee meistä sen mitä olemme. Se tekee meistä Rochen. Lisätietoja löydät osoitteesta
10001+ staff
Kcl
KCL offers a unique, open access pilot and laboratory scale environment for testing, production, scale-ups, demonstrations activities in a centralized site. KCL is an ideal platform for developing existing products and processes. It also serves as an innovative new product developer derived from furthering the science of pulp, paper and board. Biomaterial based new products can be found and developed through complete utilization of KCL’s advanced equipment and expertise. KCL provides an infrastructure where customers’ own ideas and equipment can be tailored and fitted into the process. Our in-depth knowledge and expertise is included in the services we provide our customers. We serve all customers with the highest degree of integrity and confidentiality.
11 to 50 staff
Metgen
We design and market novel enzymatic solutions for the most challenging of industrial conditions to meet our customers need. MetGen’s enzymes – MetZyme® – are industrial, highly-active, natural catalysts that accelerate chemical reactions. They can survive in harsh industrial environments which enables novel applications and combination with other enzymes. MetGen products are protected by international patents. Offering customized projects to meet customer’s specific needs, MetGen uses advances in genetic engineering and microbiology to adapt enzymes to harsh industrial conditions and to handle a variety of lignocellulosic substrates. MetGen has achieved successful industrial trials with sector leaders in the forest and renewable chemicals. In 2014 MetGen Oy has won the Best in BioFuel / BioEnergy category for the Global Cleantech Cluster Association (GCCA) 2014 Later Stage Award. The GCCA’s Global Top 10 Winners represent the best of the association’s 52 member clusters and over member companies.
11 to 50 staff
Admescope
Admescope, part of the Symeres organization, is a contract research organisation (CRO) providing the pharmaceutical, biotechnology and veterinary industry with premium quality tailor-made services to drug discovery in the area of ADME-Tox. Admescope’s unique expertise lies in in vitro & in vivo drug metabolism; including metabolite profiling & identification, drug-drug interactions and quantitative bioanalysis. The right level of research can always be found for the customer whether in the discovery or lead optimization phase. All of the services include comprehensive study consulting which enables tailoring the study according to customers’ specific needs. The state-of-art quality data is ensured by optimizing the conditions according to the compounds instead of using generic protocols. All of the data can be interpreted for the customer and helped to understand the real meaning of the numerical values and observations. Since 2020, Admescope has been part of Symeres, having capabilities to provide medicinal chemistry and integrated drug discovery and development services via the broader Symeres organization. Service Offering • in vitro Metabolism • in vivo DMPK • Drug Interactions • Quantitative Bioanalysis • Permeability & Transporters • Physicochemistry & Binding • in vitro Toxicology • Biologics • Integrated medicinal chemistry and drug discovery services via Symeres organization
51 to 200 staff
Biohit Oyj
Biohit Oyj is a globally operating Finnish biotechnology company established in 1988. Biohit's mission is "Innovating for Health". We are committed to social responsibility and it is our duty to spread knowledge about the Group I human carcinogen, acetaldehyde, and innovate and develop the marketing and availability of our products and services. Biohit is headquartered in Helsinki, Finland and its subsidiaries are located in China, Italy and the United Kingdom. Since Biohit's series B shares (BIOBV) have been listed in the NASDAQ OMX Helsinki Oy Small cap/Healthcare sector. Product range consists of products and analysis systems for the early diagnosis of gastrointestinal diseases, such as the blood-sample based GastroPanel examinations for the diagnosis of stomach illnesses and associated risks, quick tests for the diagnosis of lactose intolerance and Helicobacter pylori infection in connection with gastroscopy, and the ColonView examination for the early detection of fecal occult intestinal bleeding (faecal occult blood) that indicates a risk of colorectal cancer. Acetium innovation is developed to reduce carcinogenic acetaldehyde in the gastrointestinal tract. We are looking for distributors and licencing partners.
11 to 50 staff
Genevia Technologies
Genevia Technologies is a Finnish CRO specialized in delivering diverse bioinformatics solutions. The company was founded in 2011 as a spin-off enterprise by a group of computational systems biology researchers from Tampere University of Technology, in Tampere, Finland. Over a course of 15 years, our team has built up an extensive experience in analyzing and integrating various microarray, next-generation sequencing and proteomics data. We have also been developing and applying systems biological and mathematical modeling techniques on a wide range of applications from bacterial metabolomics to genomics of human cancers. Our mission is to facilitate the use of high-throughput genetic measurements and biological big data in life science companies and research institutions. We provide general genomics and bioinformatics consultation, support in experimental design, acquisition of cost-effective experiments, analysis and integration of data, and design of custom data analysis and visualization pipelines that organizations can use to analyze their data independently. You can find more information about our company, services and customers on our website at
11 to 50 staff
Uniogen
Uniogen is specialized in cancer diagnostics, molecular and immunoassay diagnostics of infectious diseases, and laboratory instrumentation. We are targeting the diagnostics market with new, innovative solutions under development for early cancer detection in central laboratories, and in various laboratory and decentralized healthcare settings.
51 to 200 staff
Linio Biotech
Linio Biotech is an R&D company developing a category defining regenerative injectable for natural tissue augmentation, leveraging our proprietary Tience® technology. Our goal is to create a paradigm shift in aesthetic medicine by replacing temporary fillers and invasive procedures with a safe, injectable, and biologically active product that regenerates soft tissue — naturally and sustainably. Tience® technology is already in commercial use in the Nordics and supported by clinical research and real-world data. Now, we’re taking that foundation and applying it to a new indication with global potential.
11 to 50 staff
Resistomap
Resistomap is committed to tackling one of the most pressing global health challenges: antimicrobial resistance (AMR). Founded in 2018 and based in Finland, we specialize in providing environmental surveillance services for antibiotic resistance, offering cutting-edge solutions to monitor and map the presence of resistance genes in various ecosystems, including wastewater, soil, and other environments. Using state-of-the-art molecular techniques like the SmartChip Real-Time PCR system, we deliver precise data that empowers our customers—including academic institutions, government bodies, and private companies worldwide—to understand and mitigate the spread of AMR. As a global service provider, our mission is to support efforts across the globe in combating antibiotic resistance and promoting sustainable antibiotic use through data-driven insights.
11 to 50 staff
Labmaster Ltd
Labmaster Ltd develops innovative solutions for clinical and veterinary diagnostics and research. Labmaster LUCIA™ is a point-of-care immunoassay platform based on patented cathodic electrochemiluminescence (LM-CECL) technology. It enables fast, accurate and affordable human & veterinary diagnostics including human CRP, MxA, equine SAA, equine IgG kits and many more in the pipeline. We work in a positive, international work culture with determined and motivated people. Our work is driven by our strong belief in the LM-CECL technology and the possibilities it can offer to mainstream healthcare. As a fast-paced organization working hard to create quality products that meet the IVD regulatory requirements, it is ever more important that we pay attention to the positive energy at our workplace. In this effort, our work community acknowledges every team member with their unique skills and ideas. Efforts, achievements and milestones don’t go unnoticed at Labmaster.
11 to 50 staff
Medicortex Finland Oyj
Medicortex Finland Oyj is a biotechnology company dedicated to developing diagnostics and treatments for acute neurodegenerative conditions, including traumatic brain injury (TBI) and concussion. The company is currently focusing on the development of a rapid test, based on a proprietary biomarker, for detection of TBI and concussion. Medicortex was founded by Dr. Adrian Harel in Turku, Finland, in 2014 and it operates as a public limited company. Dr. Harel has a track record in business management and leadership of early-stage biotechnology companies- Kuvaus suomeksi: Medicortex Finland Oyj on bioteknologian alan yritys, joka on keskittynyt parantamaan tapaturmaisten aivovammojen (TBI) diagnostiikkaa ja hoitoa. Yrityksen nykyinen painopiste on kehittää biomerkkiaineisiin perustuvaa diagnostiikkaa, jolla pystytään arvioimaan aivovamman laajuutta ja vaikeusastetta.
1 to 10 staff
Nordic Bioproducts Group Ltd
Nordic Bioproducts Group Oy ("NBG”), founded in 2019 as a spin-off from Aalto University, stands at the forefront of cellulose innovation, bioproduct development, and commercialization in the Nordics. At the heart of its mission is a commitment to optimizing the use of renewable natural resources while reducing the world’s dependence on fossil-based resources, fostering circular solutions, and catalyzing impactful change on a global scale. As a pioneering force, the company is dedicated to introducing breakthrough technologies and biomaterials that redefine the landscape of sustainable solutions. We help industries to combat the effects of global warming with innovative and environmentally friendly bioproducts and bioproduction technologies while generating great economic value. The bigger the scale, the better for the environment. We have technology and equipment fully ready for implementation, offering a fast track to market with bioproducts and biotechnologies.
11 to 50 staff
Protectpipe
Luonnollinen ratkaisu viemäriputkien ongelmien ennaltaehkäisyyn ProtectPipe on suomalainen mikrobiteknologiayritys, joka tuottaa innovatiivista ratkaisua, joka poistaa orgaanista jätettä viemäriputkista. Liuoksen sisältämät mikrobit kirjaimellisesti syövät putkistoon kertyvän orgaanisen jätteen. Kun orgaaninen jäte poistuu putkista, se ei pääse mätänemään ja muodostamaan syövyttävää rikkihappoa. Näin putkien eroosio vähenee ja käyttöikä pitenee. Samalla vältytään voimakkaiden viemärinavauskemikaalien käyttämiseltä ja päätymiseltä ympäristöön. Lue lisää osoitteessa
1 to 10 staff
Reagena Oy
Reagena is a biotechnology company developing, manufacturing and selling internationally proven, high quality products for healthcare laboratories, industry and pharmacies. Reagena’s core competencies include: • Development of award-winning immunological point-of-care tests and enzyme immunoassays for diagnosing infectious diseases such as lyme, tick-borne encephalitis and hantavirus • Production of reagents, staining solutions, buffers and fixatives for life sciences and industry • Execution of contract manufacturing and product development services • Distribution of leading diagnostics brands in the Nordic region Reagena products are manufactured in Toivala, Finland, according to ISO 9001 and ISO 13485 certified quality management systems. Read more at
11 to 50 staff
Tilt Biotherapeutics Ltd
TILT Biotherapeutics Ltd is a clinical stage company working in oncology towards enabling T-cell therapies and immune checkpoint inhibitors with oncolytic viruses. Embodiments of the technology will be used to enhance tumor infiltrating lymphocytes (TILs), chimeric antigen receptor T cells (CAR T) and immune checkpoint inhibiting antibody therapies. TILT was founded by Pr. Akseli Hemminki, who has published hundreds of papers in the field and treated almost 300 patients with 10 different oncolytic viruses. In 2013, Pr. Hemminki started his second company, TILT Biotherapeutics Ltd, with a technology based on his past findings in the lab, but more importantly in the clinic. The research conducted by TILT alone or in collaboration with some of world’s leading research groups with synergic technologies has generated very excellent results. The lead candidate is a clinical stage TNFα/IL2 armed oncolytic adenovirus (TILT-123 or Ad5/3-E2F-delta24-hTNFα-IRES-hIL2). Multiple Phase I clinical trials are ongoing. For contact: BD (at) tiltbio.com
11 to 50 staff
City-Lab Oy
City-Lab Oy is a privately-owned Finnish life science customer service company. We offer personal service near end-users and provide the customer with laboratory supplies, chemicals and equipments from our collaborating companies. We streamline the whole ordering process. We help customer identify their needs and compare the options available within our product portfolios. We handle technical enquiries, quote requests and provide product information in co-operation with the technical specialists. We are glad to offer multiple alternatives to our customers as many wish to compare their options. Our up-to-date information about the products, techniques, best prices and campaigns help our customer arrive to well-thought purchase decisions without wasting valuable research time. We manage the ordering process and keep track of the deliveries. We receive and handle shipments, recycle packing materials and store the products at correct temperatures for as long as needed. In case of problems, we also handle the product reclamations, invoicing corrections and other troubles the customers might face during the process. The customer enjoys all this service with no delivery fees or other extra expenses for both directly received products as well as back-orders. There is no need to buy products in big bulks or combine orders, but the customers can order whatever and whenever needed. A big part of the appeal for the customer to use City-Lab is based on the local warehouse that is constantly refined according to customers’ requirements and preferences. Our broad spectrum of suppliers covers nearly all fields of laboratory sciences, which practically makes us a onestop-shop. In the modern days of online shopping baskets and virtual service, the face-to-face customer service with familiar people and on the-spot deliveries are highly valued. In City-Lab we represent companies that share the ideologies of high quality products and customer-oriented service.
1 to 10 staff
Genomill
Genomill is unlocking the true potential of NGS for everyday healthcare with Geno1®, a radically rethought sequencing library preparation based on circular DNA and PCR-free workflows. It combines hybrid-capture–like performance with amplicon-level simplicity: targeted sequencing with minimal steps and the fastest turn-around time compared to other commercial tests. This simplicity makes sequencing faster to run, easier to automate, and practical even in low-infrastructure environments. By enabling decentralized sequencing without compromising sensitivity or scalability, Geno1® changes how next-generation sequencing can be applied in real-world healthcare. Find out more at
11 to 50 staff
Herantis Pharma Plc
Herantis Pharma Plc is a clinical-stage biotechnology company developing disease-modifying therapies for Parkinson’s disease. The Company’s lead product, HER-096, is a first-in-class small peptide that combines the neuroprotective mechanism of cerebral dopamine neurotrophic factor (CDNF), with the convenience of subcutaneous administration. In a Phase 1b clinical trial, HER 096 was shown to be generally safe and well tolerated in Parkinson’s disease patients. Herantis plans to advance HER-096 into a Phase 2 clinical trial in 2026 to evaluate efficacy, safety and tolerability in early-stage Parkinson’s patients. Herantis is listed on the Nasdaq First North Growth Market Finland.
11 to 50 staff
Nordshield
NORDShield offers bio-based anti-odor and antimicrobial textile treatment solutions that improve product performance and the end-user experience
11 to 50 staff
Valo Therapeutics Ltd
Valo Therapeutics (ValoTx) is a developer of novel immunotherapies in cancer and infectious disease. Our unique approach to immunotherapy, based on oncolytic viruses and viral vectors combined with disease-specific peptides, delivers highly adaptable and immunogenic therapeutic vaccination platforms. A spin-out company from the University of Helsinki, Finland, Valo Tx has assembled a talented team of immunotherapy experts, who together with the founding scientists have the necessary expertise to take its patented technology through clinical development and make it available to patients. The management team has a proven track record of developing successful companies from a laboratory idea to a full stock exchange listing.
11 to 50 staff
Labema Group
Founded in 1988, Labema is a Life Science and Biotechnology expert organization, that imports, promotes and delivers first class diagnostic equipment and supplies to healthcare, food industry, and research laboratories. Labema’s main expertise areas are Microbiology, Molecular biology, Food diagnostics and Drug of Abuse diagnostics. Labema’s operations are strongly based on scientific and practical expertise in diagnostic systems and processes with a focus to understand and anticipate customers’ constantly changing needs. Labema’s permanent market assessment and close partnership with customers and suppliers are the keys to its success.
11 to 50 staff
Medisapiens Ltd
MediSapiens creates cutting-edge solutions for transforming biomedical data into knowledge, insight, and value, especially with the help of genomic data. Our mission is to help our partners transform reactive and collective healthcare into proactive and personalized healthcare through better use and combination of data. Our key offering is the MediSapiens Genomics Suite, that integrates genomic data as part of your operations. We are based in Helsinki, Finland and Cambridge, United States. For more information, please visit: https://medisapiens.com/ and follow us at @MediSapiens
11 to 50 staff
Rnacious Laboratory
Why should we care about tRNA modification? Transfer RNA (tRNA) is at the heart of translation — the process at which the genetic code of an organism is deciphered into functional machines, i.e. proteins. In this process, the tRNA molecules work as adapters that proof read the code and, upon a successful match, add the correct amino acids, i.e. the building blocks that make up proteins. For this intricate process to function correctly, tRNA molecules need to be chemically modified at key positions of the molecule. This is achieved by specialised tRNA modification enzymes acting alone or as part of complex pathways. These chemical modifications provide structural integrity to the tRNA molecule and more importantly, they regulate the accuracy and speed of translation. Despite their crucial role in a core function of life, we are only beginning to understand the vast implications of tRNA modification and the complexity of the underlying mechanisms. We know that in single-celled eukaryotes, such as yeast, tRNA modifications are seldom required when the growth conditions are optimal. However, once a yeast cell lacking proper tRNA modification encounters any form of stress, severe problems in stress response systems, protein homeostasis, etc. start to emerge. The more complex the organism, the more severe the implications. In humans, a fault in only one mitochondrial tRNA modifying enzyme gives rise to severe developmental disorders, as manifested in the MERFF and MELAS syndromes. Problems in amino acid charging of tRNA molecules causes neurodegenerative diseases, such as ALS. Moreover, incorrect regulation of tRNA modification enzymes has been associated with breast cancer and various other forms of cancer
1 to 10 staff
Scellex
SCellex develops a lab method and research tool for spatial single cell sequencing directly from tissues and cells.
1 to 10 staff
Valoya Greenlux Lighting Solutions
Valoya, a horticultural brand of Greenlux Lighting Solutions, provides high-end, energy-efficient LED grow lights for crop science, vertical farming, and medicinal plant cultivation. Valoya LED grows lights have been developed using Valoya’s proprietary LED technology and extensive plant photobiology research. Valoya’s customer base includes numerous vertical farms, greenhouses, and research institutions all over the world (including 8 out of 10 world’s largest agricultural companies). The headquarters are in Helsinki, Finland and we operate globally. Greenlux Finland Oy is a pioneer in advanced LED lighting solutions in Finland. The strengths of the company are high technical knowledge and flexible customer-oriented planning and production of general lighting. Both R&D and manufacturing are in the same facility, in Finland, which enables high-quality customer service within a tight schedule.
11 to 50 staff
Alimetrics Diagnostics
Alimetrics Diagnostics is a business unit belonging to Alimetrics Research Ltd. The offering covers unique and high-quality gastrointestinal analytical services. Our innovative analysis panels, individual assays as well as the superior sample stabilisation and transport logistics are based on a long-term scientific research carried out by the sister company Alimetrics Research Ltd established in 2003. For most clients, the rationale of sample analysis is to obtain maximum information from each trial conducted; thus, a full benefit for product development, sales and marketing. Alimetrics Diagnostics team is an experienced, competent and multidisciplinary group of experts with many years of know-how in their area of specialisation. The core compentence of company is a strong scientific background and understanding of the industrial R&D requirements. email: diagnostics "@" alimetrics.com
11 to 50 staff
Enifer
We are upcycling food industry by-products into planet-friendly protein, and pioneering a new approach to food systems—one that supports healthy, delicious diets for everyone while minimizing environmental impact. Enifer, a spin-off company from VTT Technical Research Centre of Finland, was founded by five scientists in 2020 to develop and commercialize the proprietary PEKILO® technology further. A process originally developed and used by the Finnish forest industry at a commercial scale, the PEKILO® technology enables the biotechnological conversion of dilute side streams into a high-protein and fiber ingredient, PEKILO® mycoprotein.
11 to 50 staff
Kaivogen Oy - Part Of Uniogen
Kaivogen Oy is a Finnish biotech company established in 2007. The kaivo in the company name is Finnish for the well of a microplate and relates to the company’s very first products, streptavidin coated plates. Since its start up with these products, Kaivogen has extended its portfolio year by year. Current products include a wide range of assay development services from kit manufacturing to custom plate production, custom biomolecule conjugation and custom buffer preparation. In addition, we provide various streptavidin and anti-species plates and buffer products as catalogue items. Also check out our Upcon® nanoparticle-based detection technology that is well suited for lateral flow applications. Kaivogen's main customer group consists of IVD companies, for whom Kaivogen acts as an OEM manufacturer of components for IVD assays and kits. Other customer groups include research foundations and academic research groups. Around 90% of Kaivogen’s turnover each year comes from exported products, the main export destinations being the USA and the Nordic countries. Follow @uniogen to hear the latest news. Kaivogen Oy has been found to conform to the management system standards ISO 9001:2015/ISO 13485:2016 in development, manufacturing and distribution of coated microtiter plates and components for bioaffinity assays. Also our custom services, such as assay development, plate coating and protein labeling can be ISO 13485 compliant if necessary.
11 to 50 staff
Labnet Oy
Labnet Oy - trusted business partner! Our company is committed to complete customer and supplier satisfaction, and the high quality of the products. Labnet concentrates on the import, export and distribution of Life Science reagents, consumables and instruments. Our customers are research and hospital laboratories as well as pharma, biotech and industrial accounts in Finland and Estonia. The first class service provided by Labnet Oy is guaranteed by the long experience, professionalism and continuous training of our personnel. Labnet is fully owned by privately held Finnish company Holdlab Oy. Labnet Oy was founded 1971 and the company has been partner of LLG, Lab Logistics Group, since 2015.
1 to 10 staff
Nightingale Health
Nightingale Health’s mission is to build sustainable healthcare and reduce health inequalities. Nightingale Health has developed the world’s most advanced health check for the health industry. Our solution provides risk detection for multiple chronic diseases from a single blood sample. Nightingale’s Health Check can be scaled to entire populations at a low cost, and it can replace many of the current risk assessments. Detecting disease risks on a population level allows for the effective targeting and tracking of health interventions, and better prevention of the onset of chronic diseases. With every sample we help to create a healthier world.
51 to 200 staff
Puissan Biotech
We are a rapidly growing biotech startup with operations in Finland and China. Our international and multidisciplinary team develops software solutions, microfluidic devices, and provides services in the field of Life Sciences to pharmaceutical industries, research institutions, and personal care companies. At Puissan, we understand the challenges faced during drug discovery and development. Therefore, our goal is to enhance the efficiency of R&D processes by providing a unique expertise and combination of advanced computational and microfluidic tools, such as PBPK modeling and organs-on-chips.
11 to 50 staff
Bioicawtech
BioICAWtech provides chemoinformatics solutions and software development for healthcare applications. We at BioICAWtech provide research and development services for systems biology applications, next generation sequencing, biomarker identification, and many more.
1 to 10 staff
Fimm High Throughput Biomedicine Unit Htb , University Of Helsinki
HTB unit is an academic facility providing services and expertise in: – lab automation – cell-based and biochemical high-throughput screening services – access to liquid handling instruments for local researchers – chemical and siRNA libraries
11 to 50 staff
Stemsight
StemSight develops off-the-shelf regenerative cell therapies for corneal blindness. Our expertise is in the combination of iPS-derived cells with functional biomaterials - for FASTER tissue regeneration, SAFER cell therapies and EASIER cell delivery.
1 to 10 staff
Aalto-Helsinki Igem
We're an interdisciplinary group that consists of ten students from Aalto University and University of Helsinki. Our expertise is broad and the list is long. We have expertise in bioinformatics, biomathematics, mechanical engineering, translational medicine, biotechnology, molecular biosciences, genetics, graphic design, web development and product development. You can read more from our team and the members from our website Our Accomplishments 2025- Gold Medal Award, Best Measurement and Best Sustainable Development Impact Special Prize Awards, a nomination for Best Therapeutics Project, Overgrad 2024- Gold Medal Award 2023- Gold Medal Award 2022- Gold Medal Award 2021- Bronze Medal Award 2020- Gold Medal Award, Best Integrated Human Practices nomination, Best Environmental Project nomination 2019- Silver Medal Award 2018- Gold Medal Award, Best Product Design nomination 2017- Silver Medal Award, Best Applied Design nomination 2016- Gold Medal Award 2015- Gold Medal Award 2014- Best Undergraduate wiki
1 to 10 staff
Actim - Part Of Medix Biochemica
We are Actim – one of the subsidiaries of the Finnish biotechnology group Medix Biochemica. Our company specializes in developing and manufacturing innovative rapid diagnostic tests used by clinicians around the globe. At Actim, we help people around the world receive better care by helping healthcare professionals make clinical decisions in a timely manner. Our accurate and easy-to-use rapid tests aid in choosing the right treatment at the point of care. That’s the purpose we’ve always served.
11 to 50 staff
Aurlide Ltd
Aurlide Ltd. is a Finnish biotech company, service provider, and strategic partner specializing in computer-aided drug discovery and development (CADD). We offer our in silico expertise throughout all stages of preclinical drug development, from target validation to lead optimization and beyond. Our expertise spans from rational discovery and development of small molecules and macrocycles to first-in-class protein-protein interaction modulators. We also apply predictive toxicology and pharmacokinetics to ensure the success of our clients' drug candidates. Driven by our advanced technology and expertise, we’ve also initiated our own drug discovery projects, pushing the boundaries of therapeutic innovation and creating new opportunities for breakthrough treatments. Looking to innovate? Reach out, and let's explore how we can collaborate!"Aurlide – Your molecule, discovered!" Our achievements, shortly: 13 patents (as inventors) 5 clinical candidates for our customers 2 out-licensed PPI modulator discovery projects 100+ publications
1 to 10 staff
Biotus Oy
Biotus Oy on biologiseen kasvinsuojeluun erikoistunut yritys. Toiminnallamme pyrimme lisäämään biologisen kasvinsuojelun käyttöä ja alan tietämystä. Torjuntaeliöitä käytetään mm. kasvi- ja kasvuhuoneissa, tunneleissa sekä avomaamansikalla. Invertebrate bioconttrol agents producing and importing company, specialised in integrated pest management. Osan torjuntaeliöistä tuotamme itse, loput maahantuodaan suoraan niiden valmistajilta Euroopasta. Nopeat toimitukset (useana päivänä viikosta), asianmukaisesti pakattuna takaa parhaan lopputuloksen loppukäyttäjälle! Biotuksella on oma tuotemerkki kotipuutarhureiden ja muiden harrastajien tarpeita varten Torjuntaeliöiden lisäksi valikoimissamme mm. biologiset kasvitautivalmisteet sekä liima-ansat ja erilaisia feromonituotteita niin puutarha- kuin metsätuholaisille. Lisäksi ”BioNeuvo” -palvelu, johon sisältyy mm. kasvintuhoojien tunnistusapu asiakkaillemme, mansikkapunkkianalyysit sekä erilaiset kurssit ja koulutukset. Biotus Oy on IBMA:n (International Biocontrol Manufacturers' Association) sekä IOBC:n (International Organization of Biological Control) jäsenyritys.
11 to 50 staff
Entoprot Ltd
Entoprot Ltd is a company based out of Seelannintie 27, Oulu, North Ostrobothnia, Finland.
1 to 10 staff
Fhaive
We are the Finnish national laboratory for development and validation of integrated approaches to testing and assessment (IATA). Our activities comprise computational methods, toxicogenomics, molecular biology, and in vitro cell technologies.
11 to 50 staff
Innomedica Ltd
Innomedica is an international business development company specialized in licensing, distributor search and strategic planning. We provide our services to pharmaceutical, medical technology and health product companies in Europe and Japan. We have successfully supported our clients in accessing the Japanese market since 1997. See the references at our web pages.
1 to 10 staff
Misvik Biology
Misvik Biology is a precision oncology contract research organization (CRO) providing specialized HTS cell panel and ex vivo drug screening services integrated with cutting-edge multiomics analyses for customer initiated studies and personalized medicine. Our laboratory is located in Turku, Finland. Drug response testing for personalized cancer treatment: Misvik Biology is developing a diagnostic technology for precision oncology and assessment of targeted therapies for rare cancers by ex vivo testing of therapy efficacy using patient derived tumor and immune cells. The TRIALTEST™ multiomics diagnostic test can be used to predict drug efficacy integrating knowledge of molecular pathology, single cell analyses of tumor and immune cell drug responses and machine learning driven computational biology. Nanotoxicology and eNM safety governance: Misvik is invested in the development of safety governance of Engineered NanoMaterials in Europe as part of several European research initiatives and the EU NanoSafety Cluster. Our services for toxicology research include: Integrative omics methods for in vitro NanoToxicology: High-throughput organoid screening service, Big Data integration (HTS and genomics) and Predictive ToxicoGenomic testing using Tox5-Score and PTGS for liver, cardiac and renal toxicity.
1 to 10 staff
Stick Tech Ltd
Stick Tech is a Finnish high-tech company that manufactures fibre reinforcements for dental requirements. These products are already used in more than 30 countries around the globe. Stick Tech Ltd bases its activities on extensive research collaboration with numerous top universities around the world and on the continuous education and training of dental professionals worldwide.
1 to 10 staff
Syrinx Bioanalytics
SYRINX Bioanalytics is a CRO providing GLP compliant laboratory services using state-of-the-art immunological and cell based methods. Our main services are PK sample analysis, Immunogenicity testing, Biomarker analysis, Biosimilars comparability, GMP analytics and Patient Monitoring. Specialization makes SYRINX an ideal partner for pharmaceutical/biotech companies that require state-of-the-art bioanalytical support on any size program from discovery to marketed products.
11 to 50 staff
Aluke Oy
Aluke Oy, founded in 2019 by professional researchers, provides consulting services in microbiome research. We have an extensive background in environmental and human/animal host-related microbiology and microbial ecology with related bioinformatics. Having curious minds, we are actively keeping our methods updated according to the state-of-the-art approaches in sequence analysis. We provide a full-stack bioinformatic service for analysing microbiomes, starting from raw sequence data all the way to machine learning analysis of samples. We are able to analyse both amplicon sequences and metagenomic data. In addition, with our collaborators, we can organize end – to – end service including DNA extraction, library preparation and sequencing preceding the sequence analysis. Why to choose us: We can customize the analysis for your needs and assist to choose proper methods for bioinformatics/statistics or end – to – end projects. We help you to interpret the results and bring them in practice. We are able to introduce the theoretical background of the methods used. We produce high-quality visualization and reports. Aluke Oy has served customers from the private and academic sectors. We know the both sides. Letting us to help you with the bioinformatics, releases your recourses for the experimental planning and applying the research outcomes.
1 to 10 staff
Led Future
At Led Future, we believe the future of hygiene is built on innovation, sustainability, and responsibility. We specialize in advanced UVC LED technology that is ecological, energy-efficient, and designed to last. Our mission is simple yet powerful: To protect health, promote sustainability, and empower our customers with safe, effective, and environmentally friendly disinfection technologies. From workplaces and public spaces to specialized healthcare applications, Led Future devices deliver fast, simple, and reliable disinfection – without the use of chemicals. Backed by continuous research and development, we are exploring new ways to use UVC light for infection prevention and treatment in humans and animals. This scientific foundation ensures that every solution we create is both safe and effective. With an international outlook and a commitment to responsibility, fairness, and customer trust, Led Future is working to become a global leader in UVC-LED technology for disinfection.
1 to 10 staff
Avenue Biosciences
Avenue Biosciences is a biotechnology company dedicated to accelerating the discovery and development of protein biologics, so that no life-saving therapy goes unrealized because of production barriers. Headquartered in San Francisco, USA, and with laboratory operations in Helsinki, Finland, Avenue Biosciences has developed a protein engineering platform that combines organic biology and machine learning to boost protein production. The proprietary method is based on years of scientific research from the University of Helsinki, Finland. Our goal is to drive significant progress in biotechnology by providing turnkey solutions that streamline production, improve quality, and unlock new therapeutic possibilities.
11 to 50 staff
Biomush
Welcome to BioMush, where fermentation tech meets innovation. We specialize in developing all-natural umami flavoring solutions for the food industry, derived from circular ingredients in our closed-loop ecosystem. We are dedicated to creating irresistible plant-based solutions within a closed-loop ecosystem. The Challenge: Plant-based foods often lack that delicious umami taste, and clean-label options are scarce. Meanwhile, a staggering 1.3 billion tonnes of edible food is wasted yearly in production, valued between USD 0.4-1.0 trillion (Source: FAO). Our Solution: At BioMush, we have cracked the code. Our innovative, all-natural fermentation process transforms food industry side streams into umami-rich ingredients, offering a delicious solution that is clean-label, soy-free, gluten-free, and, most importantly, sustainable and circular.
1 to 10 staff
